---
schema_version: "secwatch.filing_event.v1"
accession: "0000917520-23-000054"
form_type: "8-K"
ticker: "IART"
cik: "0000917520"
company_name: "INTEGRA LIFESCIENCES HOLDINGS CORP"
filed_at: "2023-06-21T23:59:59+00:00"
generated_at: "2026-06-13T20:28:06.405479+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Integra LifeSciences appoints Lea Daniels Knight as EVP and CFO effective June 28

## Summary
- Knight brings over 30 years of experience, most recently as EVP Business Finance at Booz Allen Hamilton, and 18 years at Johnson & Johnson.
- Compensation includes $600K base salary, 90% target bonus, $1M RSU grant, $350K cash sign-on, and $1.65M 2024 LTI target.
- Jeff Mosebrook ceases as principal financial officer but remains SVP Finance and principal accounting officer.
- Appointment effective June 28, 2023; Knight succeeds interim CFO role held since February 2023.

## SEC filing metadata
- accession: 0000917520-23-000054
- form_type: 8-K
- ticker: IART
- cik: 0000917520
- company_name: INTEGRA LIFESCIENCES HOLDINGS CORP
- filed_at: 2023-06-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/917520/000091752023000054/0000917520-23-000054-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/917520/000091752023000054/iart-20230621.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000917520-23-000054
- JSON: https://secwatch.observer/filing/0000917520-23-000054.json
- Plain text: https://secwatch.observer/filing/0000917520-23-000054.txt

## Key facts
- Executive change
  Lea Daniels Knight was appointed as Executive Vice President and Chief Financial Officer at INTEGRA LIFESCIENCES HOLDINGS CORP.
  - Action: appointed
  - Role: Executive Vice President and Chief Financial Officer
  source text: On June 21, 2023, Integra LifeSciences Holdings Corporation (the “Company”) announced the appointment of Lea Daniels Knight to serve as its Executive Vice President and Chief Financial Officer effective June 28, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/917520/000091752023000054/0000917520-23-000054-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.